Autosomal Dominant Polycystic Kidney Disease
Learn about Autosomal Dominant Polycystic Kidney Disease (ADPKD), also known as Polycystic Kidney Disease Type 1 and Type 2. Find information on diagnosis, clinical documentation, and medical coding for ADPKD, including ICD-10 codes and SNOMED CT terms relevant for healthcare professionals. Explore resources for managing and treating ADPKD and understand the importance of accurate medical coding for PKD.
Inherited disorder characterized by cysts in the kidneys, leading to enlarged kidneys and kidney failure.
High blood pressure, back or side pain, headaches, blood in urine, kidney stones, and urinary tract infections.
Nephrology clinics, dialysis centers, and transplant centers. Genetic counseling is often recommended.
ICD-10 Code Families
Complete code families applicable to Q61.2
When to use each related code
| Description | When to use |
|---|---|
| Inherited kidney disease forming cysts | Use for ADPKD confirmed genetically or by family history with multiple cysts. |
| Acquired kidney cysts, not inherited | Use for multiple kidney cysts in adults without family history of ADPKD. |
| Genetic disorder with cysts in kidneys and other organs | Use for autosomal recessive polycystic kidney disease, diagnosed by genetic testing or characteristic imaging in infants/children. |
Best-practice checklist
- ✓Document family history of ADPKD, PKD1 or PKD2.
- ✓Confirm diagnosis with renal ultrasound or CT scan.
- ✓Specify ADPKD type (if known) as PKD1 or PKD2.
- ✓Document presence and severity of hypertension.
- ✓Note any extrarenal manifestations of ADPKD.
Common pitfalls to avoid
Incorrect coding for laterality (unilateral/bilateral) can impact reimbursement and data accuracy for ADPKD.
Miscoding PKD type (Type 1 vs. Type 2) affects clinical documentation integrity and research data validity.
Failure to code associated manifestations like hypertension or liver cysts can underrepresent ADPKD complexity.
Best-practice tips
- 01Control hypertension with ACE inhibitors or ARBs (ICD-10: I12.0, I15.0).
- 02Monitor kidney function with eGFR and creatinine (CPT: 82565, 82874).
- 03Manage pain with NSAIDs cautiously; consider alternatives (ICD-10: N79.0).
- 04Screen for liver and pancreatic cysts via ultrasound (CPT: 76856, 76870).
- 05Genetic counseling crucial for family planning (ICD-10: V80.1, Z83.7).
Step-by-step checklist
- 1
1. Family hx of ADPKD (ICD-10:Q61.0)?
- 2
2. Enlarged kidneys on imaging (SNOMED CT:76726007)?
- 3
3. Multiple kidney cysts confirmed by US/CT/MRI?
- 4
4. Evaluate for HTN, liver cysts, & other extrarenal manifestations
- 5
5. Genetic testing considered for diagnostic confirmation (CPT:81405)?
Ready-to-paste narrative
Patient presents with concerns regarding Autosomal Dominant Polycystic Kidney Disease (ADPKD), also known as Polycystic Kidney Disease Type 1 or PKD1. Family history is positive for ADPKD, confirming the genetic predisposition. The patient reports experiencing symptoms consistent with ADPKD, including flank pain, hypertension, and palpable abdominal masses. Renal ultrasound reveals multiple bilateral renal cysts, meeting the diagnostic criteria for ADPKD. Laboratory findings indicate a decline in glomerular filtration rate (GFR) and elevated creatinine levels, suggesting chronic kidney disease (CKD) progression. Assessment includes evaluation for intracranial aneurysms, hepatic cysts, and cardiac valvular abnormalities, common extrarenal manifestations of ADPKD. The current treatment plan focuses on blood pressure management with ACE inhibitors or angiotensin receptor blockers (ARBs), pain control, and management of CKD complications. Patient education emphasizes the importance of regular monitoring of renal function, blood pressure control, and genetic counseling for family members. Follow-up appointments are scheduled to track disease progression and adjust treatment as needed. ICD-10 code Q61.2 is used for documentation and billing purposes. The patient demonstrates understanding of the chronic nature of ADPKD and the importance of adherence to the prescribed treatment plan.
Common questions and answers
How can I differentiate between Autosomal Dominant Polycystic Kidney Disease (ADPKD) Type 1 and Type 2 in my clinical practice?+
Differentiating between ADPKD Type 1 and Type 2 can be challenging due to overlapping symptoms. While both are inherited forms of polycystic kidney disease characterized by cyst development, they differ in genetic basis, disease progression, and extrarenal manifestations. PKD1 gene mutations cause Type 1, typically leading to earlier onset and more aggressive disease progression with larger cysts predominantly in the kidneys. PKD2 mutations cause Type 2, generally resulting in later onset, slower progression, and smaller, more evenly distributed cysts. Liver cysts are more common in Type 1. Accurate diagnosis relies on genetic testing alongside clinical evaluation, including family history, imaging studies (ultrasonography, CT, MRI), and assessment of renal function. Consider implementing genetic counseling for patients and their families to understand inheritance patterns and risks. Explore how advances in genetic testing can enhance diagnostic accuracy and inform personalized management strategies for ADPKD.
What are the best evidence-based management strategies for patients with rapidly progressing ADPKD and chronic kidney disease?+
Managing rapidly progressing ADPKD with chronic kidney disease requires a multifaceted approach. Firstly, rigorously control blood pressure, ideally with an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB). Tolvaptan, a vasopressin V2 receptor antagonist, is approved for slowing cyst growth and decline in kidney function in adults at risk of rapidly progressing ADPKD. Closely monitor renal function and electrolyte levels. Address pain management with appropriate analgesics, avoiding nephrotoxic medications. Nutritional counseling plays a vital role in managing dietary restrictions and fluid intake. Consider implementing a multidisciplinary approach involving nephrologists, geneticists, and dietitians to optimize patient outcomes. Explore how clinical trials are investigating novel therapeutic targets for ADPKD to stay abreast of emerging treatment options.
What are the key considerations for pre-conception counseling for patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)?+
Pre-conception counseling is crucial for individuals with ADPKD who are planning to start a family. Openly discuss the 50% chance of inheriting the mutated gene with each pregnancy. Genetic testing can confirm the diagnosis and identify the specific gene mutation (PKD1 or PKD2) to refine risk assessment. Evaluate the patient's current disease severity, including renal function, blood pressure control, and extrarenal manifestations. Address potential pregnancy complications, such as hypertension, pre-eclampsia, and urinary tract infections. Discuss the impact of ADPKD on fertility and potential risks for both the parent and the child. Learn more about the psychosocial aspects of ADPKD and the available support resources for affected families. Consider incorporating genetic counseling into routine care for all patients of reproductive age with ADPKD.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.